scholarly article | Q13442814 |
P356 | DOI | 10.1093/INFDIS/JIW226 |
P698 | PubMed publication ID | 27234417 |
P50 | author | Martin Palus | Q59146848 |
Erik De Clercq | Q13578863 | ||
Ernest A. Gould | Q24701585 | ||
Maria João Alves | Q52804112 | ||
P2093 | author name string | Radim Nencka | |
Daniel Růžek | |||
Luděk Eyer | |||
Ivana Huvarová | |||
P2860 | cites work | Molecular targets for flavivirus drug discovery | Q21999123 |
Concurrent outbreaks of dengue, chikungunya and Zika virus infections – an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012–2014 | Q22330735 | ||
Zika Virus Associated with Microcephaly | Q22683189 | ||
Acute myelitis due to Zika virus infection | Q23014548 | ||
The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model | Q23309956 | ||
The Emerging Zika Virus Epidemic in the Americas: Research Priorities | Q24247054 | ||
Zika Virus Associated with Meningoencephalitis | Q24247064 | ||
Zika Virus as a Cause of Neurologic Disorders | Q24261288 | ||
Nucleoside inhibitors of tick-borne encephalitis virus | Q24276103 | ||
Novel approaches to flavivirus drug discovery | Q34206832 | ||
Antiviral agents acting as DNA or RNA chain terminators | Q34892252 | ||
New developments in flavivirus drug discovery | Q38769771 | ||
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase | Q42984396 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nucleoside | Q28734 |
antiviral drug | Q846227 | ||
Zika virus | Q202864 | ||
P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
P304 | page(s) | 707-11 | |
P577 | publication date | 2016-05-27 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Nucleoside inhibitors of Zika virus | |
P478 | volume | 214 |
Q53682362 | A Review of the Ongoing Research on Zika Virus Treatment. |
Q47280870 | A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity |
Q38157419 | A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses |
Q66680603 | Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells |
Q27463110 | Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus |
Q38156667 | Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives |
Q51336416 | Adverse outcomes of pregnancy-associated Zika virus infection. |
Q36147591 | An Approach for Zika Virus Inhibition Using Homology Structure of the Envelope Protein |
Q28581011 | Analysis of Ribonucleotide 5’ -Triphosphate Analogs as Potential Inhibitors of Zika Virus RNA-dependent RNA Polymerase Using Non-Radioactive Polymerase Assays |
Q53693795 | Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. |
Q47547159 | Blocking Zika virus vertical transmission |
Q99603820 | Broad-spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View |
Q29994527 | Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond |
Q49796493 | Characterisation of Zika virus infection in primary human astrocytes. |
Q37677916 | Commentary: Teratogenic effects of the Zika virus and the role of the placenta |
Q43046702 | Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro |
Q58122069 | Complementary Mechanisms Potentially Involved in the Pathology of Zika Virus |
Q86939020 | Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus |
Q37698482 | Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5. |
Q30145530 | De novo RNA synthesis catalyzed by the Zika Virus RNA polymerase domain |
Q56342513 | Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting the Zika virus |
Q92188514 | Development of Small-Molecule Inhibitors Against Zika Virus Infection |
Q63246230 | Development of a fluorescence-based method for the rapid determination of Zika virus polymerase activity and the screening of antiviral drugs |
Q28954597 | Epidemiology, Prevention, and Potential Future Treatments of Sexually Transmitted Zika Virus Infection |
Q40080931 | Escape of tick-borne flavivirus from 2' -C-methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness |
Q28804198 | Evaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous System |
Q33794343 | Global Alert: Zika Virus-an Emerging Arbovirus |
Q90419101 | Importance of Zika Virus NS5 Protein for Viral Replication |
Q95301704 | In vitro Studies on The Inhibition of Replication of Zika and Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus cervicornis |
Q38158000 | Inhibition of autophagy limits vertical transmission of Zika virus in pregnant mice |
Q61053965 | Natural Products Isolated from Oriental Medicinal Herbs Inactivate Zika Virus |
Q54256710 | Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses. |
Q30145642 | Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika |
Q47095447 | Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides |
Q43039888 | RNA-dependent RNA polymerase: Addressing Zika outbreak by a phylogeny-based drug target study |
Q58099567 | Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection |
Q38156553 | Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae |
Q41925559 | Sophoraflavenone G Restricts Dengue and Zika Virus Infection via RNA Polymerase Interference |
Q38867867 | Structural basis of Zika virus methyltransferase inhibition by sinefungin |
Q47555436 | Structural biology of Zika virus and other flaviviruses |
Q48504896 | Structure and function of Zika virus NS5 protein: perspectives for drug design. |
Q56353961 | The A-Z of Zika drug discovery |
Q29051492 | The Race To Find Antivirals for Zika Virus |
Q25707196 | The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication |
Q28595139 | The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication |
Q56000954 | The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors |
Q49215219 | The structure of the binary methyltransferase-SAH complex from Zika virus reveals a novel conformation for the mechanism of mRNA capping |
Q93078517 | Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go |
Q41918254 | Therapeutic Approaches for Zika Virus Infection of the Nervous System |
Q65054977 | Using Macaques to Address Critical Questions in Zika Virus Research. |
Q38158967 | Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication |
Q26693468 | Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia |
Q60919470 | Zika Virus: Origins, Pathological Action, and Treatment Strategies |
Q40037723 | Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic? |
Q29647477 | Zika puzzle in Brazil: peculiar conditions of viral introduction and dissemination - A Review |
Q55084405 | Zika vaccines and therapeutics: landscape analysis and challenges ahead. |
Q50020968 | Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options. |
Q28278045 | Zika virus: from pathogenesis to disease control |
Search more.